Pharmapack Technologies (India) Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.09 Cr
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 54.20%
- Profit Growth -87.98%
- Ebitda -24.98%
- Net Worth 1.12%
- Total Assets 8.59%
About Pharmapack Technologies (India)
Pharmapack Technologies (India) Private Limited (PTIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 17 December 2018 (Six years and two months 3 days old ). Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Ecj Packaging Technologies India Private Limited. The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tak Keung, Mohd Khan, and Nizamuddin Khaja serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909TG2018FTC129074
-
Company No.
129074
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
17 Dec 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pharmapack Technologies (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tak Keung
|
Director | 17-Dec-2018 | Current |
Mohd Khan
|
Director | 17-Dec-2018 | Current |
|
Nizamuddin Khaja
|
Director | 27-Mar-2023 | Current |
Financial Performance of Pharmapack Technologies (India).
Pharmapack Technologies (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 54.2% increase. The company also saw a substantial fall in profitability, with a 87.98% decrease in profit. The company's net worth moved up by a moderate rise of 1.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmapack Technologies (India)?
In 2023, Pharmapack Technologies (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmapack Technologies (India)?
Pharmapack Technologies (India) has a workforce of 23 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmapack Technologies (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmapack Technologies (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
